MetaADEDB 2.0 @ LMMD
Norinyl
(BFPYWIDHMRZLRN-SLHNCBLASA-N)
Structure
SMILES
C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O
Type(s)
Approved
ATC code(s)
G03AA01; G03AA02; G03AA03; G03AA04; G03AA05; G03AA06; G03AA07; G03AA08; G03AA09; G03AA10; G03AA11; G03AA12; G03AA13; G03AA15; G03AA16; G03AB01; G03AB02; G03AB03; G03AB04; G03AB05; G03AB06; G03AB07; G03AB09; G03CA01; L02AA03
Molecular Formula:
C20H24O2
Molecular Weight:
296.403
Log P:
3.6126
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
40.46
CAS Number(s):
57-63-6
Synonym(s)
1.
Norinyl
2.
Norinyl 1-50
3.
Ortho Novum
4.
Ortho-Novum
5.
Orthonovin
External Link(s)
MeSHC014715
PubChem Compound5991
BindingDB50187243
ChEBI4903
CHEMBLCHEMBL691
DrugBankDB00977
DrugCentral1082
IUPHAR/BPS Guide to PHARMACOLOGY7071
KEGGcpd:C07534
dr:D00554
Therapeutic Target DatabaseD06NXY
ZINC3812897
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1BronchitisFAERS: 1US FAERS
2Chemical injuryFAERS: 1US FAERS
3Drug ineffectiveFAERS: 1US FAERS
4LaryngitisFAERS: 1US FAERS
5NauseaFAERS: 1

View details

CTD
US FAERS
6PainFAERS: 119264124CTD
US FAERS
7Product packaging confusionFAERS: 1US FAERS
8Pulmonary HypertensionFAERS: 1US FAERS
9Respiratory distressFAERS: 1US FAERS
10SinusitisFAERS: 1US FAERS
11SyncopeFAERS: 1US FAERS
12VomitingFAERS: 1

View details

CTD
US FAERS
13Abdominal PainCanada Vigilance: 1Canada Vigilance
14Abnormalities, Drug-Induced29458080CTD
15Acne Vulgaris

View details

CTD
16AcneCanada Vigilance: 1Canada Vigilance
17Adenocarcinoma

View details

CTD
18AgitationCanada Vigilance: 1Canada Vigilance
19AlopeciaCanada Vigilance: 1Canada Vigilance
20Amenorrhea2576253
2576255
CTD
21Anemia, Macrocytic9169341CTD
22Anemia, Megaloblastic974714CTD
23Angioedema12870385CTD
24Anorexia9169341CTD
25Anovulation26820455CTD
26Aphasia98825
4413961
5641510
CTD
27Arterial Occlusive Diseases788979CTD
28Arteriosclerosis11256880CTD
29Arthritis, Experimental15885639CTD
30ArthritisCanada Vigilance: 1Canada Vigilance
31Atrial septal defect 2830309CTD
32Brain Ischemia3529368CTD
33Breast Diseases12616963CTD
34Budd-Chiari Syndrome20038345CTD
35Cardiovascular Diseases3284149CTD
36Cerebral Infarction7034891CTD
37Chemical and Drug Induced Liver Injury

View details

CTD
38Chest PainCanada Vigilance: 1Canada Vigilance
39ChloasmaCanada Vigilance: 2Canada Vigilance
40Cholestasis

View details

CTD
41Chorea5571013CTD
42ConstipationCanada Vigilance: 1Canada Vigilance
43Coronary Occlusion12748457CTD
44Cystitis6790651CTD
45Depressive disorder7750278
10574641
CTD
46DermatitisCanada Vigilance: 2Canada Vigilance
47Diarrhea19443681CTD
48Disorders of Sex Development

View details

CTD
49Dizziness

View details

CTD
50Dysmenorrhea10574641
12499030
12616963
CTD
51Dyspepsia19443681CTD
52Ear Neoplasms2414260CTD
53Ebstein Anomaly830309CTD
54Edema1182631
24096037
24992288
CTD
55Emotional disorderCanada Vigilance: 1Canada Vigilance
56Endometrial Neoplasms65687CTD
57Endometriosis30675821CTD
58Erythema Nodosum5697233CTD
59Facial paralysis5411921CTD
60Fatigue9169341
19443681
CTD
61Fatty Liver15345470CTD
62Feeding and Eating Disorders19443681CTD
63Feminization3284149
23143038
24832493
CTD
64Fibroadenoma of breastCanada Vigilance: 1Canada Vigilance
65Folic Acid Deficiency9169341CTD
66Gynecomastia1182631CTD
67Hamartoma4414279CTD
68Headache

View details

CTD
69Heart Diseases6938012CTD
70Heart failure3529368CTD
71Hemianopsia4413961CTD
72Hemorrhage2821645CTD
73Hepatomegaly28108177CTD
74Hirsutism12615818
15269926
CTD
75Hyperplasia1361882
24096037
29526645
CTD
76Hypertension, Renovascular788979CTD
77Hypertrophy21783948
24096037
CTD
78Hypocalcemia820624CTD
79Hypolipoproteinemias6631239CTD
80Hypospadias16569931
16945680
CTD
81Insulin Resistance29935216CTD
82Intestinal Neoplasms3396013CTD
83Intracranial Embolism and Thrombosis9673837CTD
84Intracranial Hypertension98825CTD
85Intracranial Thrombosis4714850
5725158
CTD
86Jaundice, Obstructive1738330CTD
87Kidney Diseases19761811CTD
88Liver Neoplasms, Experimental

View details

CTD
89Liver neoplasms

View details

CTD
90Melanosis12499032CTD
91Menorrhagia4414279CTD
92Mesothelioma2414260CTD
93Metrorrhagia2150581
9115001
CTD
94Monoclonal Gammopathy of Undetermined Significance820501CTD
95Mood Disorders399315CTD
96Myocardial Infarction4702663CTD
97Myocardial Ischemia

View details

CTD
98Neoplasms, Multiple Primary48099
170431
CTD
99Neurotoxicity Syndromes29782159CTD
100OnychoclasisCanada Vigilance: 1Canada Vigilance
101Panic Disorder11578682CTD
102Papilledema4413961CTD
103Paresis4413961
5641510
5725158
CTD
104Peliosis Hepatis4130279CTD
105PhlebitisCanada Vigilance: 1Canada Vigilance
106Pityriasis Lichenoides4692137CTD
107Polycystic Ovary Syndrome2777199
12615818
CTD
108Precancerous Conditions6278220
8824503
9615764
CTD
109Prenatal Exposure Delayed Effects19864446
24632129
29097150
CTD
110Prolactinoma8784065CTD
111Prostatic Diseases15867144CTD
112Prostatic Hyperplasia1708755
2208075
CTD
113Prostatic Neoplasms

View details

CTD
114Pruritus2511971
15861022
16919318
CTD
115Psychotic Disorders4179717CTD
116Pulmonary EmbolismCanada Vigilance: 2820501
2945082
CTD
Canada Vigilance
117Sexual and Gender Disorders19864446CTD
118Sinus Thrombosis, Intracranial20500972CTD
119Skin Ulcer9169341CTD
120Sleep Initiation and Maintenance Disorders9169341
9628521
CTD
121Spermatocele16709447CTD
122StomatitisCanada Vigilance: 1Canada Vigilance
123Substance Withdrawal Syndrome7010171CTD
124SwellingCanada Vigilance: 1Canada Vigilance
125Tachycardia9169341CTD
126Taste Disorders19443681CTD
127Tetany820624CTD
128Thermal burnCanada Vigilance: 1Canada Vigilance
129Thromboangiitis Obliterans7034891CTD
130Thromboembolism1182631
2086334
5677208
CTD
131Thrombophilia11994571CTD
132ThrombophlebitisCanada Vigilance: 17750278CTD
Canada Vigilance
133ThrombosisCanada Vigilance: 17404306
15669648
CTD
Canada Vigilance
134Tricuspid Atresia830309CTD
135Urethral stricture15867144CTD
136Urogenital Abnormalities19864446CTD
137Uterine Anomalies25242408CTD
138Uterine Cervicitis5411921CTD
139Uterine Neoplasms10667565
14692618
CTD
140Venous Thromboembolism

View details

CTD
141Venous Thrombosis

View details

CTD
142Ventricular Fibrillation2023523CTD
143Vision Disorders1747706CTD
144Vulvovaginal burning sensationCanada Vigilance: 1Canada Vigilance
145Vulvovaginal pruritusCanada Vigilance: 1Canada Vigilance
146Weight Gain8222658
10574641
CTD
147Xanthomatosis5124256CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.